Skip to the content
HomeHow it Works
EmployerHealth PlanPublic SectorProviderPharma
--------------
Digital Therapeutics
AIHealth Security
Community Well-being IndexBlue Zones Project
AllergiesCancerCoronavirusDiabetes Type 2Heart DiseaseHypertensionQuitting SmokingWomen's HealthSee All
Find a DoctorAskMDRealAgeSharecare WindowsSharecareRx
HomeHow it Works
EmployerHealth PlanPublic SectorProviderPharma
--------------
Digital Therapeutics
AIHealth Security
Community Well-being IndexBlue Zones Project
Health Topics
View All
AllergiesCancerCoronavirusDiabetes Type 2Heart DiseaseHypertensionQuitting SmokingWomen's HealthSee All
Health Tools
Find a DoctorAskMDRealAgeSharecare WindowsSharecareRx
Types
ArticlesSlideshowsVideo
Condition Education Centers
View All
An Anti-Inflammatory Diet PlanDiabetes Smart TipsLiving Well with Rheumatoid ArthritisLiving Well with Colitis or Crohn'sManage Your Child's ADHDManaging Relapsing Multiple SclerosisTalking to Your Doctor About Hepatitis CTalking to Your Doctor About PsoriasisTalking to Your Doctor About Rheumatoid ArthritisYour Guide to Diabetes ManagementYour Guide to Managing Depression
  • About Sharecare
  • Leadership
  • Editorial Policy
  • Blog
  • Press Center
  • Health Equity
  • Investor Relations
  • Contact Us
Back to In The News

In its search for a new FDA commissioner, the White House is relying on insiders for advice

Author:
Arty Diaz
Share:

©2021 Sharecare, Inc.

AdChoicesCookiesDO NOT SELL MY DATAPrivacyTerms
About
About SharecareLeadershipEditorial PolicyPress CenterInvestor RelationsBlogCareersContact UsHelpSitemap
Health Topics
AllergiesCancerCoronavirusDiabetes Type 2Heart DiseaseHypertensionWomen's HealthView all
Health Tools
Find a DoctorDiscount MedicationAskMDSharecare Windows